TAMPA, Fla., Sept. 17, 2022 /PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis
/PRNewswire/ The US FDA has granted an Investigational Exemption (IDE) approval Device for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent.
/PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent.
/PRNewswire/ The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent.